To investigate the molecular basis of endothelial cell-specific gene expression, we have examined the DNA sequences and the cognate DNA-binding proteins that mediate transcription of the murine tie2\tek gene. Reporter transfection experiments conformed with earlier findings in transgenic mice, indicating that the upstream promoter of Tie2\Tek is capable of activating transcription in an endothelial cell-specific fashion. These experiments have also allowed the identification of a single upstream inhibitory region (region I) and two positive regulatory regions (regions U and A) in the proximal promoter. Electrophoretic mobility-shift assays have allowed further characterization of three novel DNA-binding sequences associated with these regions
INTRODUCTION
The endothelium occupies a pivotal position at the interface between the circulating humoral and cellular elements of the blood and the solid tissues that constitute the various organs. In this unique position, endothelial cells regulate a large number of critical processes. Such processes include leukocyte adherence and transit through the blood vessel wall, local control of blood vessel tone, modulation of the immune response, and the balance between thrombosis and thrombolysis. It is not surprising that endothelial cell dysfunction has been postulated as a central feature of vascular diseases such as hypertension and atherosclerosis.
The endothelial cell has also been the object of research investigating the developmental processes regulating the formation of blood vessels [1] . Classical embryological studies have shown that most embryonic blood vessels develop through a process termed vasculogenesis, characterized by the in situ differentiation and organization of endothelial precursor cells into capillary-like structures [1] [2] [3] [4] [5] . The formation of vessels by sprouting and branching from existing vessels is termed angiogenesis and has also been shown to contribute to vascular formation in specialized organs of the embryo such as brain and kidneys [4, 6] . Recent studies employing targeted mutations of several endothelial cell-specific tyrosine kinase receptors, including Flk1, Flt1, Tie1 and Tie2\Tek, have provided new insight into early endothelial cell development [7] [8] [9] [10] . A targeted mutation of Flk1 causes a failure of differentiation of precursor Abbreviations used : BAEC, bovine aortic endothelial cell ; C/EBP, CCAAT-box-binding proteins ; DTT, dithiothreitol ; EMSA, electrophoretic mobilityshift assay ; RLU, relative light unit ; rp, ribosomal protein ; SV40, simian virus 40 ; UTR, untranslated region ; VSMC, vascular smooth muscle cell ; vWf, von Willebrand factor ; YSC, yolk salk cell.
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and have provided preliminary characterization of the protein factors binding to these elements. Two of the elements (U and A) confer increased transcription on a heterologous promoter, with element U functioning in an endothelial-cell-selective manner. By employing embryonic endothelial-like yolk sac cells in parallel with adult-derived endothelial cells, we have identified differences in functional activity and protein binding that may reflect mechanisms for specifying developmental regulation of tie2\tek expression. Further study of the DNA and protein elements characterized in these experiments is likely to provide new insight into the molecular basis of developmental-and cellspecific gene expression in the endothelium.
cells into a more mature endothelial cell phenotype, resulting in a lack of blood vessel development and defective vasculogenesis [7] . In contrast, mice lacking Flt1 have an increased number of endothelial cells with disorganized and dilated vascular networks. This suggests that Flt1 plays a role in the organization of the embryonic vasculature once endothelial cell differentiation has occurred [8] . A targeted mutation of Tie1 results in less dramatic morphological abnormalities ; however, significant functional abnormalities are evident, characterized by diffuse oedema and localized haemorrhage due to a ' leakage syndrome ' [10] . The tie2\tek knock-out mouse also has a characteristic phenotype with a diminished number of endothelial cells and abnormal branching and sprouting of blood vessels, suggesting a role for Tie2\Tek factor in the process of angiogenesis [10] . Thus each of these factors plays a distinct and unique role in the development of a normal vascular system. The normal expression of each is required for endothelial cell functions that regulate lineage development, vascular morphogenesis and the organization and integrity of blood vessels once they are formed. Despite the significant contribution of these studies to the understanding of vascular development, most of the data remain descriptive. Further interpretation of the phenotype of these genetic models and further understanding of vascular development in general will require greater knowledge of the origin and differentiation of the endothelial cell lineage. To pursue these fundamental questions in endothelial cell biology, this laboratory and others have investigated mechanisms of transcriptional regulation in this cell type. By comparison with experiments in the myogenic and haematopoietic lineages, such work has aimed at the characterization of cell-specific transcription factors. Toward this end, a large number of studies have investigated the cis-acting DNA elements and trans-acting protein factors that regulate transcription of the following endothelial cell genes : plasminogen activator inhibitor-1, granulocyte-macrophage colony stimulating factor, endothelin-1, thrombomodulin, von Willebrand factor (vWf), platelet-derived growth factors A and B, intracellular cell adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin, P-selectin, tissue factor, angiotensinconverting enzyme, inducible and constitutive NO synthase, superoxide dismutase, Flk1 and Flt1 [11] . This work has taught us surprisingly little about the fundamental mechanisms that mediate cell-specific transcription in endothelial cells.
A limitation of studies to date is that they have been conducted with promoter sequences that cannot direct endothelial cellspecific expression in transgenic animals, or have not been evaluated in transgenic animals. The probability of identifying cell-specific elements should be greatly increased if experiments in itro are conducted with a minimal cell-specific region as delineated in i o. Promoter regions of four endothelial cell genes have been shown to direct cell-restricted expression in the endothelium in transgenic mice : the murine endothelin-1 promoter, the human vWf promoter and the promoters of two homologous murine tyrosine kinase receptors, Tie1 and Tie2\Tek [12] [13] [14] [15] . The murine endothelin-1 promoter also directs transcription in epithelial cells, making it a less desirable gene for study. The vWf promoter targets expression of the transgene only to a subpopulation of endothelial cells limited to the yolk sac and adult brain. While reporter expression in transgenic animals directed by the Tie1 and Tie2\Tek promoters is not as universal in embryonic endothelial cells as the endogenous promoters, expression is seen in a majority of the endothelium throughout most of development. Since the Tie2\Tek promoter has been most extensively investigated in transgenic animals, this promoter was chosen for experiments in itro aimed at identifying the DNA and protein elements that direct cell-specific transcription in endothelial cells.
Here, we report the cloning and initial characterization of the 5h regulatory region of the murine tie2\tek gene. Reporter gene transfection studies reveal that the upstream promoter and first untranslated exon contain a single inhibitory sequence and multiple positive regulatory elements. Footprinting analysis and electrophoretic mobility-shift assays (EMSA) have allowed an initial definition of the protein-binding sequences in these regions and a preliminary evaluation of the interacting proteins. While each of these sites also binds proteins in non-endothelial cells, one element (element B) appears to bind factors that are developmentally regulated in endothelial cells. Another novel element (element U) is capable of activating transcription of a heterologous promoter in an endothelial cell-selective manner. These data reveal the surprising complexity of this endothelial cell-specific promoter and provide for more definitive studies investigating the molecular nature of the factors that regulate transcription of this gene in the endothelium.
MATERIALS AND METHODS

Cloning and mapping of tie2/tek regulatory regions
Using reverse-transcriptase PCR of murine yolk sac cell (YSC) RNA, two PCR primers 5h-CTTGTAAACAAGAGCGA-GTGGAC and 5h-CCATTCTCTGGTCACATCTTGAG were used to amplify 369 bp spanning the 5h end of the tie2\tek cDNA and a part of the 5h-untranslated region (5h-UTR). This DNA fragment was employed to screen a 129SV\J mouse genomic library constructed in Lambda Fix II (Stratagene, La Jolla, CA, U.S.A.). Clones thus isolated were restriction mapped and exons were identified by hybridization. Restriction fragments were subcloned into Bluescript II KS (Stratagene, La Jolla, CA, U.S.A.) for further mapping and nucleotide sequence analysis. Dideoxy chain-termination sequencing was performed with Sequenase 2.0 according to the manufacturer's instructions (Amersham, Cleveland, OH, U.S.A.). Each DNA was sequenced at least twice from both directions and sequence analyses were performed using the GCG software package (Genetics Computer Group, Madison, WI, U.S.A.).
Reporter gene construction
For functional analysis of the upstream regulatory region, a series of 5h deletion constructs was generated. A HindIII-HindIII and a HindIII-BamH1 restriction fragment spanning 2.3 kb and 471 bp of the Tie2\Tek promoter and 5h-UTR respectively were subcloned into pGL2 basic vector (Promega, Madison, WI, U.S.A.), linearized with Sac1 and subjected to exonuclease III and S1 nuclease digestion, blunt-ended with T4 DNA polymerase and re-ligated. The sequence of each deletion construct was determined by nucleotide sequence analysis. For analysis of the two regulatory regions U and A in association with a heterologous promoter, oligonucleotides encoding binding sequences were concatamerized and cloned upstream of the minimal simian virus 40 (SV40) promoter in the pGL2 promoter vector (Promega). Single-stranded oligonucleotides (regions A and U) were annealed and multimerized as previously described [16] . All constructs were subjected to DNA sequencing to confirm the size and sequence of the end product.
Cell culture and transfection studies
The murine YSC used in this study were supplied by Progenitor Inc. (Menlo Park, CA, U.S.A.), with culture medium consisting of alpha-minimal essential medium supplemented with 18 % (v\v) fetal bovine serum, leukaemia inhibitory factor, 2-mercaptoethanol and gentamycin [17, 18] . Bovine aortic endothelial cells (BAEC) and rat aortic vascular smooth muscle cells (VSMC) were harvested and cultured as previously described [19] . HeLa, HepG2 (human hepatoma), 3T3 (mouse fibroblast), C6 (rat glioma), LLC1 (rat lung carcinoma), 143B (human osteosarcoma), C2C12 (myoblast) and JEG-3 (human choriocarcinoma) cell lines were obtained from American Type Culture Collection (Rockville, MD, U.S.A.) and grown in Dulbecco's modified Eagle's medium supplemented with 10 % (v\v) fetal bovine serum, penicillin (100 units\ml), streptomycin (100 µg\ml) and glutamine (2 mM). All media and tissue culture reagents were purchased from Life Technologies (Grand Island, NY, U.S.A.).
Transient transfection of all cell lines was performed using lipofectamine according to the manufacturer's instructions (Life Technologies), except for 3T3 fibroblasts which were transfected using the calcium phosphate method [20] . Briefly, cells were seeded in six-well plates at approximately 4i10& cells per well in 2 ml of medium. Twenty-four hours later at 50-70 % confluence, cells were washed twice with PBS and co-transfected with 1 µg of pGL2 plasmid and 1 µg of control SV40\LacZ plasmid. For the lipofectamine method, 6 µl of lipofectamine was incubated with DNA in a 210 µl Optimem (Life Technologies) for 15 min at 37 mC and cells were transfected for a period of 4 h, after which the transfection solution was removed and replaced with fresh medium. Forty-eight hours after transfection, cells were washed twice with PBS and lysed in 140 µl of cell culture lysis reagent (Promega). The lysate was vortexed, subjected to one freeze-thaw 
* Indicates the reporter vector construct p( )tek-luc used in the transfection experiments. These constructs are identical with those used in Figure 2 . † Indicates that the reporter vector construct was not tested in VSMC. 
* Location of the wild-type oligonucleotide relative to the transcription start site of the corresponding gene. † Underlined nucleotides represent the bp mutations.
cycle and briefly centrifuged and 20 µl of the supernatant was assayed for luciferase and β-galactosidase activity. Relative light units (RLU) were calculated as the ratio of light units obtained with the Tie2\Tek promoter construct divided by the value obtained with the promoterless pGL2 basic plasmid, and the resulting number was divided by absorbance obtained in the β-galactosidase assay. For HeLa, HepG2 and VSMC, transcriptional activity is expressed as the ratio of RLU in these cells compared with RLU measured in BAEC (Table 1) . Transfections were done in triplicate and conducted a minimum of twice with each construct.
DNAse I footprinting and EMSA
Nuclear extracts for both footprinting and EMSA were prepared from different cell lines according to the method of Dignam et al. [21] . For DNAse I footprinting analysis, the Pst1-Sty1 restriction fragment of the Tie2\Tek promoter was dephosphorylated, endlabelled and digested with BamH1 and the BamH1-Sty1 fragment was used as a probe for the footprinting reaction of the non-coding strand of the promoter. Binding reaction mixtures consisted of 50 mM NaCl, 10 mM Hepes (pH 7.9), 1 mM MgCl # , 1 mM CaCl # , 100 µg BSA, 1.4 mM 2-mercaptoethanol, 10 % (v\v) glycerol, 5 µg poly(dI-dC) and 40 µg of YSC nuclear extract in a final volume of 50 µl. After digestion with DNAse I (Worthington Biochemical Corporation, Freehold, NJ, U.S.A.) at a final concentration of 40 units\ml for 30 s at 4 mC, the product was electrophoresed on a 7 % polyacrylamide gel. Maxam-Gilbert sequencing was performed as previously described [20] .
The oligonucleotides used in EMSA are listed in Table 2 .
These oligos were end-labelled with [$#P]ATP using T % polynucleotide kinase (New England Biolabs, Beverly, MA, U.S.A.). Two conditions were used for binding reactions (20 µl total volume). Condition 1 (medium salt, MS) consisted of 40 mM NaCl, 50 mM KCl, 10 % (v\v) glycerol, 10 mM Tris\HCl (pH 7.5), 2 mM dithiothreitol (DTT), 2 µg poly(dI-dC) and 0.8 mg\ml BSA. Condition 2 (medium salt with Hepes and magnesium, HM) consisted of 40 mM NaCl, 60 mM KCl, 5 mM MgCl # , 10 mM Hepes (pH 7.8), 1 mM EDTA (pH 8.0), 2 µg poly(dI-dC) and 1 mM DTT. For EMSA in Figure 4 (element U), condition HM was used and electrophoresis was performed with 0.5iTris\borate\EDTA running buffer. For EMSA in Figure 5 (element A), binding was conducted with condition MS, and electrophoresis was performed in 1iTris\ glycine buffer [20] . For EMSA in Figure 6 (element B), binding condition MS was used, and samples were electrophoresed in 0.5iTris\borate\EDTA running buffer. Nuclear extracts (7.5 µg) from the various cell lines were incubated with the binding reaction mixture for 10 min at room temperature. Labelled probe (0.2-0.5 ng) and excess cold oligonucleotide (100-fold unless otherwise indicated) were added and reactions were incubated at room temperature for an additional 20 min before being loaded onto the gel and electrophoresed at 200 V at 4 mC for 4-6 h, fixed, dried and exposed to film.
RESULTS
Cloning of the Tie2/Tek promoter region
The cloning of the 5h portion of the murine tie2\tek gene has been reported previously [13] . We have extended the characterization of this gene by cloning and performing detailed
Figure 1 Genomic organization of the murine tie2/tek locus
Top : restriction mapping analysis of the 18 kb tie2/tek locus and a 2.3 kb region (HindIII-HindIII) spanning the proximal promoter and the 5h-UTR. The first exon is indicated by a hatched box, the second exon by a black box and the transcription start site by an arrow. Bottom : nucleotide sequence of the immediate upstream promoter region and the 5h-UTR employed in these studies. The transcription start site is indicated by an arrow and the first nucleotide is designated j1. The 5h-ends of reporter constructs containing variable lengths of promoter sequence are indicated by vertical arrows and negative numbers. All of these constructs terminate at the HindIII site at j318. Sequences identified by DNAse I footprinting are underlined with broken lines and oligonucleotide probes employed in protein binding and enhancer trap experiments are indicated by brackets.
mapping of 18 kb of the genomic sequence. Included in this region are approximately 8 kb of upstream sequences, the first and second exons and the first 7 kb intron (Figure 1, top) . Similar to many genes expressed in early embryogenesis, tie2\tek lacks a consensus TATA sequence [22] . Sequences containing the functional regions of the promoter are presented in Figure 1 , bottom. Numbering is relative to the transcription-initiation site as previously reported [13] . As indicated, reporter constructs resulting from a 5h deletion series have the HindIII site at j318 bp as their 3h end, and their 5h end is indicated by an arrow and a negative number (Figure 1, bottom) .
Reporter transfection experiments
As a first approach to identifying the DNA sequences that regulate transcription of the tie2\tek gene, a series of deletion constructs were generated and transfected into adult-derived BAEC, endothelial-like embryonic YSC and several non-endothelial cell types. YSC are derived from murine yolk sac tissue at approximately 8.0 days of embryonic development and are used in these studies as a model of embryonic endothelial cells. These cells express endothelial markers such as Flk1 and Tie2\ Tek and are capable of forming microvascular-like tubular structures in itro, even without being plated on Matrigel ( [17] and results not shown). Furthermore, these cells are clonal and long-lived in culture, and have high transfection efficiency. Nonendothelial cells include the epithelial cell line HeLa, the hepatoma cell line HepG2 and primarily cultured rat aortic VSMC.
Figure 2 Luciferase activity of various Tie2/Tek reporter plasmids
A series of constructs derived by 5h-nested deletion were evaluated by transfection into BAEC and embryonic YSC. Relative luciferase activity is the luciferase activity of the Tie2/Tek reporter normalized to the promoterless luciferase vector (pGL2 basic) and to the β-galactosidase activity resulting from co-transfection with a constitutive β-gal vector. The increase in transcriptional activity in BAEC following the deletion of the DNA sequence from k153 bp to k105 bp suggests that this region (region I) contains one or more negative regulatory elements. The decrease in transcriptional activity detected in both BAEC and YSC with deletion of sequences from k105 bp to k96 bp and from k68 bp to k65 bp suggests the presence of two positive regulatory regions, regions U and A respectively.
Transfection studies using the Tie2\Tek promoter constructs revealed cell-type-specific expression in cultured endothelial cells. The largest restriction fragment employed in reporter constructs was a 2.3 kb HindIII-HindIII fragment containing approximately 2.0 kb of upstream sequence [ Figure 1 (top) and Figure  2 ]. This sequence includes the region that has been shown to direct endothelial cell-specific gene expression in transgenic mice [13] . This 2.3 kb region of the Tie2\Tek promoter was proven to be cell-specific in cultured cells (Figure 2) . Transfection of this reporter construct resulted in high levels of luciferase activity in BAEC. While the level of activity of the reporter constructs was considerably less in YSC than in BAEC, it was still significantly higher than in non-endothelial cells, which had levels of activity barely greater than the promoterless pGL2 basic plasmid (Table  1) . This cell-specificity in itro was demonstrated for all of the constructs evaluated, indicating that even the most proximal promoter elements may be involved in restricting expression in cultured endothelial cells.
Transfection of the series of upstream deletion constructs identified a number of regulatory regions. Since the transcriptional activity obtained with p(k2000)tek-luc was equivalent to that obtained with the p(k153)tek-luc construct in both BAEC and YSC, detailed analysis of upstream sequences focused on the region between k153 bp and the transcription start site. While activity of the k2000 bp and k153 bp constructs was similar in both BAEC and YSC, there was a significant increase in activity in BAEC when the region between k153 bp and k105 bp was removed from the reporter construct ( Figure 2) . As is evident from the error bars, the variance in these experiments was extremely low, indicating that the almost 2-fold increase in activity is statistically significant. This increase most likely represents the deletion of sequences that function in this context as a transcriptional repressor. Interestingly, there is no evidence for such inhibitory activity conferred by this sequence in YSC, suggesting that the DNA-binding proteins that confer this inhibition may not be present, or may not be active, in the embryonic YSC. Also, deletion of the sequence between k153 bp and k105 bp did not affect transcription in non-endothelial cells (Table 1) . Inspection of the nucleotide sequence between k153 bp and k105 bp reveals no known consensus DNA-binding sites.
Analysis of more proximal deletion constructs identified two positive regulatory domains in the upstream Tie2\Tek promoter. The construct containing 96 bp of promoter region, p(k96)tekluc, exhibited less than half the activity of the construct containing 105 bp of the promoter sequence, p(k105)tek-luc (Figure 2) . A similar loss of activity was observed in YSC with deletion of this region of promoter sequence (Figure 2 ). While there is no known consensus DNA-binding site in this region, there is a repeated 5 bp sequence (CATAC) between k99 bp and k90 bp, and one of these repeats is missing in the p(k96)tek-luc construct. A second decrease in luciferase activity was detected in both BAEC and YSC, with deletion of sequences between k68 bp and k65 bp. As is evident from the promoter sequence, the three nucleotides which are not present in the p(k65)tek-luc construct are part of a CAAT sequence. This region has a similar DNA sequence to the consensus CAAT motif that interacts with members of the C\EBP (CCAAT-box-binding protein) family of transcription factors [23] . Further deletion of sequences between k65 bp and k31 bp did not result in any significant change in transcriptional activity in either BAEC or YSC (Figure 2 ).
Protein-binding experiments
To obtain an initial correlation of protein-DNA interactions with these functional observations, DNAse I footprinting was conducted in itro. A DNA fragment containing the transcription start site and the upstream promoter region (k153 bp to j67 bp) was end-labelled and subjected to DNAse I digestion in the presence or absence of YSC nuclear extract. These experiments revealed protection from DNAse I digestion in two regions of the Tie2\Tek promoter (Figure 3) . The most 5h footprinted region, region A, extends from bps k76 to k57, and a more proximal region, region B, extends from bps k38 to k20. Region A includes the functional sequence between bps k68 and k65 identified in earlier transfection experiments [ Figure 1 (top) and Figure 2 ]. Information from reporter gene and footprinting experiments was employed to direct EMSA analysis of DNA binding sites. In order to investigate the pattern of protein binding to the oligonucleotide probes, two different binding conditions were employed, along with two different electrophoresis conditions.
Initial EMSA studies investigated the functional region between k105 bp and k96 bp, designated region U ( Table 2) . These experiments revealed specific interaction with binding protein present in nuclear extract derived from YSC ( Figure 4) . To define further the binding sequence, a probe was constructed with mutations in both of the CATAC repeats (GCATACC-ATACA GCGATCCACGAA). This mutU probe was not able to compete for binding to the native sequence and was not able to bind protein when radiolabelled and employed as a probe under various conditions (Figure 4 ). This 12 bp element defined by these studies has not been previously characterized, suggesting that the protein(s) identified represent a new class of DNAbinding factor(s). This element binds the same protein(s) in YSC, BAEC and HeLa, indicating that the interacting factor(s) is not restricted to endothelial cells (results not shown). Under other binding conditions, two bands were apparent and both bands could be competed out by the addition of excess cold probe (results not shown). It seems most likely that these bands represent binding by protein to one or both of the repeated
Figure 3 DNAse I footprinting of the non-coding strand of the proximal Tie2/Tek promoter region
End-labelled DNA was subjected to DNAse I digestion in the presence and absence of YSC nuclear extract as detailed in the Materials and methods section. Maxam-Gilbert GjA and CjT sequencing reactions were conducted with the same labelled DNA fragment. Region A, previously identified in transfection studies, is noted as Footprint A. Region U, also identified in transfection studies, is not evident on DNAse footprinting analysis. However, a previously unidentified protein-binding site, Footprint B, is seen and extends from k38 bp to k20 bp. sequences in the probe, suggesting that CATAC represents the basic binding sequence.
EMSA were also employed to investigate protein interactions with the sequence identified as region A. Since functional studies had indicated an important role for the sequence between k68 bp and k65 bp, probes were designed to contain these bps and a minimal amount of flanking sequence (Table 2 ). This oligonucleotide was capable of binding proteins present in YSC, BAEC and HeLa cells (results not shown). Analysis of the DNA sequence of this oligonucleotide showed that it contains a CAAT motif that may represent the binding site for members of the C\EBP family of DNA binding proteins. However, excess of cold oligonucleotides encoding a CAAT consensus sequence were not able to compete for binding to this Tie2\Tek promoter element (results not shown).
Additional experiments were employed to characterize the binding sequence in region A as well as the proteins that bind this site. To determine whether the CAAT sequence is a part of the binding site, three point-mutations were introduced in the oligonucleotide (CAA GTC) ( Table 2 ). This mutA probe appeared to compete partially for binding to the native sequence, so the stoichiometry of this competition was evaluated in more detail. EMSA indicated that the mutant was 5-fold less effective than the native sequence at competing for binding, but was capable of completely inhibiting binding at high (100-fold) molar excess ( Figure 5, bottom) . More significantly, a radiolabelled mutA probe did not exhibit any specific binding (Figure 5, top) .
Figure 4 EMSA employing oligonucleotide probes encoding functional region U
Labelled oligonucleotides encoding wild-type and mutant region U sequences (see Table 2 ) were employed in EMSA with nuclear extract derived from YSC. Under the conditions employed in this experiment, specific binding is represented by a single retarded band indicated by an arrowhead. A cold probe containing mutations in the CATAC repeats is unable to compete for binding and a labelled mutant probe is unable to bind protein.
Further experiments were thus conducted to determine whether this sequence binds members of the C\EBP family of transcription factors. First, oligonucleotides encoding the classical CAAT consensus sequence could not compete for binding to the wild-type region A probe ( Figure 5, top) . Also, when the consensus CAAT motif was employed as a probe, C\EBP protein binding was noted to produce a much slower-migrating complex. While binding of this complex could be competed out by cold consensus CAAT oligonucleotide, binding was not competed out by cold region A oligonucleotide. Taken together, these data suggest that the CAAT sequence constitutes part of the binding site in region A, but it does not represent a classical CAAT box consensus sequence ; i.e. it does not bind C\EBP factors.
EMSA experiments were also conducted using oligonucleotide probes encoding region B, as identified by DNAse I footprinting analysis. The region B probe produced a highly retarded complex in YSC, and a complex of similar size was seen with extracts from HeLa, C2C12 myoblast and myotube cell lines (Figure 6, top) . Interestingly, this complex was not seen with BAEC. Instead, the BAEC extract produced a specific and more rapidly migrating complex. This complex was also observed with extracts from all cell types except YSC. With YSC likely to represent a less differentiated endothelial cell phenotype, the differences in the binding patterns may suggest differences in binding proteins between embryonic and adult endothelial cells.
Since region B binds developmentally regulated proteins, we searched for similar sequences in other early endothelialspecific genes. Both Flk1 and Flt1 were found to have similar sequences in their upstream promoter regions (Table 2 ) [24, 25] . Oligonucleotides encoding these sequences were employed in EMSA studies. These probes were neither able to compete with the Tie2\Tek probe for protein binding nor bind protein in YSC nuclear extract (Figure 6, bottom) . A search of
Figure 5 EMSA employing oligonucleotide probes encoding region A identifies specific binding proteins, and these proteins are distinct from those which bind consensus CAAT box sequences
Top : labelled oligonucleotides encoding region A, mutated region A and a consensus CAAT motif were employed in EMSA with nuclear extract derived from YSC. Probe A produces a single specific retarded band under these experimental conditions, as indicated by an arrowhead. Excess of cold probe A is able to compete out protein binding completely, whereas cold mutant probe A can compete out part of the binding, and cold CAAT consensus probe cannot compete out any of the binding. Furthermore, radiolabelled mutant probe A is not able to produce a specific binding pattern. However, the labelled CAAT consensus probe does produce a specific binding pattern, indicated by an arrow, with bands more retarded than those produced with probe A. Bottom : titration competition experiments with probe A and the mutant probe A. A 25-fold excess of the cold probe A is able to compete effectively for all binding to the radiolabelled probe, while a 100-fold excess of cold mutant is required to compete for all binding to the labelled probe A. Specific binding is indicated by an arrowhead.
the various transcription-factor databases failed to identify a known consensus binding sequence in this region. On further analysis, region B is found to contain a TGAAAAT sequence that shares considerable homology with an element, TGA- AAAAT, previously characterized in the TATA-less ribosomal protein S16 (rpS16) promoter [26] . Also, the location of this sequence in the Tie2\Tek promoter at approximately k30 bp is identical with the location of the homologous sequence in the rpS16 gene [26] .
Earlier experiments in transgenic mice have suggested the presence of important positive regulatory element(s) in the upstream Sac1-Sph1 region (region S, extending from k753 bp to k537 bp). Transgenes lacking this region fail to demonstrate any significant endothelial expression of the reporter gene, thus
Table 3 Transcriptional enhancement by regions U and A in the context of a heterologous promoter
Results are presented as relative luciferase activity in different cell types. Oligonucleotides encoding four copies of region U or region A were cloned upstream of the minimal SV40 promoter in the plasmid pGL2 promoter and evaluated by transfection into BAEC, 3T3 (fibroblasts), HeLa, C6 (glioma), LLC1 (lung tumour), 143B (osteosarcoma) and JEG3 (choriocarcinoma) cells. Concatamers of region U increase transcription 6.5-fold in BAEC, with only a minimal increase in most other cell types. Concatamers of region A provide a modest increase in transcription in all cell types except JEG3, where they confer a 5.7-fold increase.
Relative luciferase activity Cells Construct … pGL2 promoter pGL2 promoterjU pGL2 promoterjA BAEC indicating the presence of one or more elements that are critical for the transcriptional activation and\or cell-restricted expression of tie2\tek. Using this 223 bp fragment as a probe in EMSA, a single retarded DNA-protein complex was observed in nuclear extracts from YSC (results not shown). Analysis of the DNA sequence of the Sac1-Sph1 fragment identified two potential binding sites for regulatory factors. A CCAAT sequence is located at k654 bp, which may represent the binding site for a variety of C\EBP proteins. Another consensus sequence, ATT-TGCAT, located at k677 bp represents the binding site for members of the octamer binding family of transcription factors.
Heterologous promoter-reporter gene transfection experiments with regions U and A
To verify further that the sequences identified in functional studies as regions U and A are capable of independently regulating transcription, their activity was evaluated in a luciferase reporter plasmid employing a minimal viral promoter. For these experiments, oligonucleotides encoding the sequence of interest were concatamerized, and resulting fragments containing four copies of the region of interest were subcloned into the reporter plasmid. The activity of the resulting vectors was compared with the parent pGL2 promoter plasmid (Table 3) . Region U oligonucleotides increased the rate of transcription approximately 7-fold in BAEC, and this increase was cellrestricted. In most other cell types there was only a minimal 1.5-2-fold increase in transcription, with a moderate increase of 3-fold in 143B osteosarcoma cells and JEG3 choriocarcinoma cells. Region A oligonucleotides had a more universal effect, increasing transcription approximately 2-3-fold in all cell types, except JEG3 where they produced a 6-fold increase. Thus both regions A and U increase transcription of a heterologous promoter, and each region has a unique pattern of transcriptional activity, as exhibited by the relative activity in these different cell types.
DISCUSSION
Identification of multiple regulatory elements in the tie2/tek gene
The current study represents a detailed analysis of a promoter region that is capable of directing endothelial cell-specific gene expression in i o. Using the Tie2\Tek promoter, we have identified several novel regulatory elements that are important for its transcriptional activity (summarized in Figure 7 ). Similar to other genes that are expressed during early development, tie2\tek has a TATA-less promoter. Most of the transcriptional activity of this promoter in cultured adult-derived BAEC and endothelial-like embryonic YSC is contained within the proximal promoter and the 5h-untranslated region spanning k153 bp to j324 bp. Reporter transfection experiments have identified an upstream inhibitory region (region I) and two upstream positive regulatory elements (U and A). Protein-binding experiments have allowed the characterization of an additional region, region B, located just upstream of the transcription start site. The DNA element within region U has been defined at the nucleotide level and consists of a 12 bp motif containing a CATAC repeat (GCATACCATACA). While this element binds nuclear factor(s) derived from both endothelial and HeLa cells, it is capable of activating the transcription of a heterologous promoter, preferentially in endothelial cells rather than in nonendothelial cell types. The consensus DNA-binding sequence of this element is novel, which suggests that the cognate DNAbinding proteins are likely to represent a new family of such factors.
Another binding site, region A, has been identified within the proximal promoter and consists of a 28 bp DNA sequence. The binding element contained in this region has not been completely defined ; however, a CAAT sequence contributes to the recognition site. Despite similarities in the binding motif, region A does not represent a consensus CAAT box and does not bind C\EBP factors, as demonstrated by EMSA. This suggests that the factor(s) that bind this element may also represent a new family of DNA-binding proteins. Data from transfection and protein-binding experiments suggest that this element interacts with ubiquitously expressed factor(s).
The most proximal element, element B, consists of a 26 bp DNA sequence identified by footprinting analysis. The precise binding motif within this region has not been fully defined. Of interest is the presence of a TGAAAAT sequence within this element located 30 bp upstream of the transcription start site. Hariharan and Perry [26] have previously identified a homologous sequence, TGAAAAAT, located 30 bp upstream of the transcription start site of the TATA-less rpS16 gene [26] . This element was shown to bind a yet unidentified nuclear factor distinct from conventional TATA-binding proteins and is likely to function as a TATA box counterpart. While mutation of this element in the rpS16 gene abolished binding by EMSA, identical mutations within region B of the Tie2\Tek promoter (TGA-AAATG TGCTCCTC) caused a significant decrease in, but not a total loss of, binding (results not shown). These data suggest that this 8 bp sequence is likely to be a part of a larger protein-binding domain. Because of the location of the binding site and its homology to the rpS16 element, it would seem likely that element B functions as a TATA box counterpart for the TATA-less tie2\tek gene. This also suggests that this region may interact with the basal transcription apparatus either directly or via a ' tethering ' factor [26] . The fact that two different proteins bind this element in YSC and BAEC suggests developmental differences in the expression of tie2\tek. This is likely to result in a switch of the rate of transcription at different stages of endothelial cell development and may explain the differences in the transcriptional activity of the tie2\tek construct in BAEC compared with YSC.
Correlation of findings in vitro with transgenic experiments in vivo
Some of the in itro findings demonstrated in the current study correlate well with previous data in transgenic mice, while in some cases there are differences. Most significantly, the 2000 bp region upstream of the transcription start site of tie2\tek, shown to be cell-specific in transgenic mice, is also cell-specific in transfection experiments. However, differing from the transgenic data, experiments in itro indicate that even the minimal promoter contains elements that can specify endothelial cell expression. Another finding in common is the presence of important positive regulatory elements within the first untranslated exon. In transgenic animals, constructs lacking j67 bp (Sty1 site) to j323 bp (HindIII site) were noted to have diminished reporter gene expression [13] . Using reporter transfection experiments, we have identified positive regulatory elements between j107 bp and j233 bp and between j233 bp and j255 bp (results not shown). Further delineation of the DNA sequences responsible for this activity and correlation with protein binding experiments are currently underway.
Experiments in transgenic animals have identified an upstream enhancer located between k753 bp (Sac1 site) and k537 bp (Sph1 site) (region S), which proved to be critical for in i o transcription of the LacZ reporter transgene in embryonic endothelial cells (Figure 7 ) [13] . Using protein-binding experiments, we have identified protein factor(s) that specifically interact with this region (results not shown). However, experiments in itro reported here showed that the deletion of this region had no effect on the transcriptional activity of the Tie2\Tek promoter in either BAEC or YSC. These findings may suggest that the proteins binding this region are unable to function outside of the chromosome, or that these regulatory factors need to cooperate with additional factors to modulate endothelial cell-specific expression. There are examples of DNA elements that have been characterized in association with other genes that are capable of regulating transcription in i o, but have little effect on transcription of transfected reporter constructs [27] . In some cases, these elements appear to function simply to open the chromatin, and in other cases they have enhancer-like activity which requires chromosomal integration for productive interactions with a promoter region [27, 28] .
Possible mechanisms of endothelial cell-specific gene expression
Despite the significant new information provided by this study, the mechanisms underlying cell-specific expression of tie2\tek are not fully defined. Possible mechanisms for determining cellspecific expression involve binding of a cell-restricted transcriptional regulator to its target sequence or the interaction of a ubiquitous DNA-binding protein with a cell-specific transcriptional coactivator. The tissue-restricted expression of tie2 may be mediated in part through the GCATACCATACA element characterized within region U. This element is capable of significantly activating transcription of a heterologous promoter in endothelial cells and to a much lesser degree in several nonendothelial cell types. However, the protein binding this element is not cell-restricted, as is evident in a similar pattern of binding in endothelial and HeLa cells using EMSA. These findings suggest that if element U contributes to cell-specific expression of tie2\tek, this has to reside in the interaction of promoters and enhancers with histones, and the potential for this interaction to determine cell-restricted transcription. It is well established that removal of histone-controlled repression is a necessary step for the activation of many silent eukaryotic genes [29] . Thus, despite the presence of the same transcription factor in a variety of cell types, activation of transcription may take place in some but not in others, depending on the state of the chromatin and whether it can be ' opened ' to uncover essential regions of DNA for interaction with these factors [29] . Analysis of DNA-protein interactions using footprinting in i o in endothelial and nonendothelial cells may help determine the sites of endothelial cellspecific interaction.
Another possible mechanism for determining tissue-specific expression resides in region S, which is known to be essential for the endothelial expression of tie2\tek reporter transgenes [13] . We have shown that this region is capable of binding factors present in embryonic endothelial-like YSC (results not shown). Analysis of DNA sequences within this region have identified two potential sites for interaction with regulatory factors. A CCAAT sequence, located at k654 bp, may serve as the binding site for a variety of C\EBP factors. A member of this family, C\EBPα, is known to direct terminal differentiation and cellspecific transcription in both adipocytes and liver cells [30, 31] . Region S also contains a consensus octamer site, ATTTGCAT, known to bind members of the POU domain family of transcription factors [32] . One of these factors, Oct-1, has a ubiquitous pattern of expression and regulates the transcriptional activity of many genes, including the immunoglobulin genes [32] . B-Cellrestricted expression of the immunoglobulin genes is determined by Bob-1 (also termed OCA-B and OBF-1), a specific coactivator of Oct-1 that is expressed exclusively in B-cells. A second mechanism of cell-specific expression mediated by the octamer motif may involve its interaction with cell-restricted POU-domain transcription factors that are distinct from Oct-1. Several of these transcriptional regulators such as Pit-1, Sprm-1, Skn-1 and NOct factors have been well characterized and are expressed in a cell-specific manner. These factors are known to regulate the cellrestricted expression of genes in the pituitary gland, male germ cells, epidermis\hair follicles and neurons respectively [32] [33] [34] [35] . Since region S is required for optimal expression of tie2\tek in i o, it remains possible that a cell-restricted coactivator of Oct-1 or a cell-restricted POU-domain transcription factor is responsible for mediating endothelial cell-specific expression.
